Kahana-Edwin, S.; Torpy, J.; Cain, L.E.; Mullins, A.; McCowage, G.; Woodfield, S.E.; Vasudevan, S.A.; Shea, D.P.T.; Minoche, A.E.; Espinoza, A.F.;
et al. Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine. Cancers 2024, 16, 12.
https://doi.org/10.3390/cancers16010012
AMA Style
Kahana-Edwin S, Torpy J, Cain LE, Mullins A, McCowage G, Woodfield SE, Vasudevan SA, Shea DPT, Minoche AE, Espinoza AF,
et al. Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine. Cancers. 2024; 16(1):12.
https://doi.org/10.3390/cancers16010012
Chicago/Turabian Style
Kahana-Edwin, Smadar, James Torpy, Lucy E. Cain, Anna Mullins, Geoffrey McCowage, Sarah E. Woodfield, Sanjeev A. Vasudevan, Dan P. T. Shea, Andre E. Minoche, Andres F. Espinoza,
and et al. 2024. "Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine" Cancers 16, no. 1: 12.
https://doi.org/10.3390/cancers16010012
APA Style
Kahana-Edwin, S., Torpy, J., Cain, L. E., Mullins, A., McCowage, G., Woodfield, S. E., Vasudevan, S. A., Shea, D. P. T., Minoche, A. E., Espinoza, A. F., Kummerfeld, S., Goldstein, L. D., & Karpelowsky, J.
(2024). Quantitative ctDNA Detection in Hepatoblastoma: Implications for Precision Medicine. Cancers, 16(1), 12.
https://doi.org/10.3390/cancers16010012